2015 in pharma — approvals, patent cliffs, Phase 3 readouts
FDA / EMA / MHRA approvals (34)
- — Defitelio · Jazz Pharms Inc · Oncology
- — Eucrisa · Anacor Pharms Inc · Immunology
- — Spinraza · Biogen Idec · Other
- — Akovaz · Infectious Disease
- — NUSINERSEN SODIUM
- — Fluocinolone Acetonide · Eurofarma · Immunology
- — GOSOGLIPTIN · Other
- — Alprolix · Swedish Orphan Biovitrum AB · Metabolic
- — Zepatier · Merck & Co. · Oncology
- — Anthim · Elusys Therapeutics Inc · Other
- — Lartruvo · Eli Lilly · Oncology
- — Nuplazid · Acadia Pharms Inc · Neuroscience
- — Tecentriq · Roche · Oncology
- — PIMAVANSERIN TARTRATE
- — Briviact · UCB · Metabolic
- — Taltz · Eli Lilly · Immunology
- — Exondys 51 · Sarepta · Rare Disease
- — Zepatier · Merck & Co. · Infectious Disease
- — Xiidra · Bausch Health · Immunology
- — E-Z-Hd · Gastroenterology
- — Axumin · Blue Earth Diagnostics Ltd · Oncology
- — Methylthioninium Benzalkonium Chloride Hydrate · Oncology
- — GRAZOPREVIR ANHYDROUS
- — Eucrisa · Anacor Pharms Inc · Immunology
- — Idelvion · CSL Behring GmbH · Rare Disease
- — Rubraca · Pfizer
- — Adlyxin · Sanofi-Aventis Us Llc · Metabolic
- — Zinplava · Merck & Co. · Infectious Disease
- — Cinqair · Teva Respiratory Llc · Respiratory
- — Ocaliva · Intercept Pharms Inc · Metabolic
- — TRAFERMIN
- — Radium bromatum · Bayer Hlthcare · Oncology
- — GALLIUM OXODOTREOTIDE
- — Rubidium Bromatum · Jubilant · Metabolic